<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045378"><TermName>procarbazine</TermName><TermPronunciation>(proh-KAR-buh-zeen)</TermPronunciation><TermDefinition><DefinitionText>The active ingredient in a drug that is used to treat advanced Hodgkin lymphoma and is being studied in the treatment of other types of cancer. Procarbazine blocks cells from making proteins and damages DNA. It may kill cancer cells. It is a type of antineoplastic agent and a type of alkylating agent.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705392" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;procarbazine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705393" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;procarbazina&quot;" language="es" id="_4"/><SpanishTermName>procarbazina</SpanishTermName><SpanishTermDefinition><DefinitionText>Ingrediente activo de un medicamento que se usa para tratar el linfoma de Hodgkin en estadio avanzado y que está en estudio para tratar otros tipos de cáncer. La procarbazina impide que las células elaboren proteínas y daña el ADN. Puede destruir células cancerosas. Es un tipo de antineoplásico y un tipo de alquilante.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-02-17</DateLastModified></GlossaryTerm>
